Market open

MAIA Biotechnology Inc./$MAIA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Ticker

$MAIA

Trading on

AMEX

Industry

Biotechnology

Employees

13

ISIN

US5526411021

MAIA Metrics

BasicAdvanced
$58M
-
-$1.05
0.21
-
$58M
0.21
$2.74
$1.40
239K
2.651
2.527
-297,494.91%
-119.60%
-1,131.02%
14.11
14.11
-2.77
-29.74%
-23.81%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MAIA

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs

What’s the current market cap for MAIA Biotechnology Inc. stock?

What is the P/E ratio for MAIA Biotechnology Inc. stock?

Does MAIA Biotechnology Inc. stock pay dividends?

When is the next MAIA Biotechnology Inc. dividend payment date?

What is the beta indicator for MAIA Biotechnology Inc.?